EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress

    NEXT STORY
    Global $8.2Bn Oligonucleotide Synthesis Market by 2024 – Opportunities in Emerging Asian Markets
    PREV STORY
    HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging

    author_avatar
    NASDAQ Market News

    Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018

    Multiple key efficacy outcomes further improved in open-label extensions of systemic sclerosis (SSc) and ...

    author_avatar
    NASDAQ Market News